Cellectis S.A.
CLLS
$3.59
$0.092.57%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4,575.85% | 102.48% | -30.93% | -406.11% | 125.69% |
| Total Depreciation and Amortization | -22.65% | -0.12% | 1.74% | -2.76% | 7.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 27.82% | -53.73% | 184.92% | 142.53% | -205.18% |
| Change in Net Operating Assets | 91.80% | -36.44% | -9.33% | -313.21% | 241.72% |
| Cash from Operations | -559.45% | 84.76% | 39.92% | -36,410.64% | 99.19% |
| Capital Expenditure | 59.44% | -287.21% | 22.78% | 28.18% | 29.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,114.60% | 95.69% | -1,234.95% | 128.66% | -169.71% |
| Cash from Investing | 752.46% | 93.47% | -1,348.33% | 125.35% | -174.60% |
| Total Debt Issued | -- | -- | -- | -- | 6,158.18% |
| Total Debt Repaid | 0.68% | -0.59% | -3.53% | -5.26% | 8.40% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 30.38% | 18.13% | -27.81% | 30.09% | 11.11% |
| Cash from Financing | 2.82% | 0.26% | -4.43% | -239.83% | 169.35% |
| Foreign Exchange rate Adjustments | -21.41% | 422.31% | -137.46% | 168.71% | 8.22% |
| Miscellaneous Cash Flow Adjustments | -200.00% | -- | -- | -- | 200.00% |
| Net Change in Cash | 222.79% | 88.85% | -334.37% | 1.40% | -257.65% |